ArticleCureus2026

First-in-Human Randomized Controlled Pilot Trial of a Maxillofacial Drug Delivery Platform for Low-Dose Systemic Delivery.

Sajani Ramachandran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.